preview

Ebola And The Human Body

Good Essays

Ebola vs. the Human Body
Wilson, Carolyn. "Induction of Ebolavirus Cross-species Immunity Using Retrovirus-like Particles Bearing the Ebola Virus Glycoprotein Lacking the Mucin-like Domain." Virology Journal Volume 9.32 (2012). Induction of Ebolavirus Cross-species Immunity Using Retrovirus-like Particles Bearing the Ebola Virus Glycoprotein Lacking the Mucin-like Domain. BioMed Central. Web. 7 Sept. 2014. <http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284443>.
Micro-Babes
There are numerous viruses that society can contract, but one that has scientists talking today is Ebola. When Ebola is mentioned, we immediately think of one particular virus, but this fearless disease is in fact one of five species: Sudan ebolavirus (SUDV), Zaire …show more content…

An infectious and generally fatal disease, up to ninety percent lethality, is marked by fever and an attack on the immune system, which is spread through contact with infected body fluids by a filo virus whose normal host species in unknown (Oxford, 2012). This deadly virus is killing thousands of people, and is a major threat to today’s society, which leads to the need of finding an antigen that will reduce the chances of a worldwide epidemic event. We will be discussing the ebolavirus cross-species immunity within these five strains that has scientist talking today. The availability of a vaccine that provides cross-protection against the many different strains of the virus is essential for the preparedness against natural outbreaks (Wilson). Some vaccines demonstrate evidence of cross-protection, frequent induced species-specific immune response and protection (Wilson). GP, glycoprotein, is the sole viral antigen in several ebolavirus candidate vaccines. GP1,2 is present on the surface, and links together with other GP1 to GP2 trimmers to form a disulfide bond (Figure 1). MLD, mucin-like domain, often thought of as forming a glycan cap is highly diverse among different ebolaviruses and is also highly N- and O-glycosylated. The MLD-glycan cap is hypothesized to be a target for antibody response and may serve as a decoy to change an antibody response to a more conserved region of the virus envelope (Wilson). VLP,

Get Access